Loading…
The Cigna Group is projected to rise to $341.29 by 2027, a +16% move from its current price of $293.46. CI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $289.63 | $293.53 | $297.48 | +0.02% |
| Jul 14 | $288.09 | $293.59 | $299.20 | +0.05% |
| Jul 15 | $286.93 | $293.66 | $300.55 | +0.07% |
| Jul 16 | $285.97 | $293.73 | $301.69 | +0.09% |
| Jul 17 | $285.14 | $293.79 | $302.72 | +0.11% |
| Jul 18 | $284.39 | $293.86 | $303.65 | +0.14% |
| Jul 19 | $283.71 | $293.93 | $304.52 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $283.71 | $293.93 | $304.52 | +0.16% |
| Week 2 | $280.02 | $294.40 | $309.51 | +0.32% |
| Week 3 | $277.33 | $294.87 | $313.51 | +0.48% |
| Week 4 | $275.15 | $295.34 | $317.01 | +0.64% |
| Week 5 | $273.30 | $295.81 | $320.18 | +0.80% |
| Week 6 | $271.67 | $296.28 | $323.12 | +0.96% |
| Week 7 | $270.22 | $296.76 | $325.89 | +1.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.
The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations.
The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
The Cigna Group trades under the symbol CI and is currently priced at $282.08. It holds a market cap of $74.62B and is ranked 207 by market capitalization among listed securities.
The 2026 forecast shows a min of $258.08, an avg of $282.08 and a max of $364.74 with a neutral signal and 0% ROI, reflecting a neutral near-term outlook. Longer horizon forecasts imply a bullish trajectory, with 2030 averaging $416.23 and a max of $567.86 (ROI 47.6%), 2040 averaging $965.01 and a max of $1,472.62 (ROI 242.1%), and 2050 averaging $1,952.64 and a max of $3,193.70 (ROI 592.2%).
A major floor 12.1% below — a decisive break under it would weaken the trend.
The nearest floor, 7.7% below — buyers have tended to step in here.
Price is pressing into resistance (1.5% away) — a breakout level to watch.
A major ceiling 7.2% above — clearing it would confirm fresh momentum.
Key CI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $288.72 | Buy | $289.56 | Buy |
| MA 10 | $284.56 | Buy | $287.00 | Buy |
| MA 20 | $285.75 | Buy | $285.72 | Buy |
| MA 50 | $285.69 | Buy | $284.11 | Buy |
| MA 100 | $280.18 | Buy | $282.48 | Buy |
| MA 200 | $280.35 | Buy | $284.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.41 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 91.50 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 1.17 | Buy |
| ROC (12) | 3.67 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.01 | Sell |
| Awesome (5,34) | 4.02 | Buy |
| Ultimate (7,14,28) | 72.72 | Sell |
| Momentum (10) | 11.59 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 293.61 | Sell |
| ADX (14) | 11.15 | Neutral |
| ATR (14) | 3.71 | Info |
The near-term sentiment is NEUTRAL with RSI14 at 50. The stock is trading around its key moving averages, with SMA50 at $283.82 and SMA200 at $281.32.
In the last 30 days, the price ranges from a low of $256.80 to a high of $309.85. Support is identified at $270.73 and resistance at $300.71, indicating a balanced to slightly consolidative near-term setup.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $258.08 | $293.46 | $375.11 | 0% | Neutral | |
| $279.51 | $341.29 | $435.70 | +16% | Neutral | |
| $276.23 | $343.62 | $450.53 | +17% | Neutral | |
| $308.22 | $389.33 | $521.33 | +33% | Bullish | |
| $347.77 | $445.22 | $606.91 | +52% | Bullish | |
| $397.73 | $515.41 | $713.69 | +76% | Bullish | |
| $454.48 | $595.59 | $836.45 | +103% | Bullish | |
| $462.43 | $612.39 | $871.18 | +109% | Bullish | |
| $482.94 | $645.92 | $929.85 | +120% | Bullish | |
| $523.31 | $706.54 | $1,028.44 | +141% | Bullish | |
| $749.65 | $1,055.63 | $1,610.26 | +260% | Bullish | |
| $1,427.74 | $2,156.24 | $3,525.67 | +635% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $258.08 | $293.46 | $343.74 | +0.00% |
| August 2026 | $250.87 | $293.69 | $351.30 | +0.08% |
| September 2026 | $254.72 | $299.62 | $361.18 | +2.02% |
| October 2026 | $252.22 | $297.91 | $361.46 | -0.57% |
| November 2026 | $251.01 | $297.50 | $362.96 | -0.14% |
| December 2026 | $257.27 | $305.91 | $375.11 | +2.82% |
Click any year to see its month-by-month CI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CI is projected to trade between $258.08 and $375.11, averaging $293.46 — a potential gain of 0% from today's $293.46. A consolidation phase looks the most probable path here.
The Cigna Group's 2027 outlook centres on $341.29, within a $279.51 to $435.70 range. That is up +16% on the projected 2026 average. That marks a +16% change versus current levels. Price action looks broadly range-bound.
By 2028, CI could reach as high as $450.53, with a base case around $343.62 and support toward $276.23 — roughly +17% from $293.46. A consolidation phase looks the most probable path here.
Expect CI to range from $308.22 to $521.33 through 2029. The $389.33 average target implies a +33% move from current prices. That is up +13% on the projected 2028 average. Momentum favours further upside here.
The CI price prediction for 2030 points to an average of $445.22 (low $347.77, high $606.91) — a potential gain of +52% on today's $293.46. Buyers look set to stay in control over this stretch.
In 2031, CI is projected to trade between $397.73 and $713.69, averaging $515.41 — a potential gain of +76% from today's $293.46. That is up +16% on the projected 2030 average. Momentum favours further upside here.
The Cigna Group's 2032 outlook centres on $595.59, within a $454.48 to $836.45 range. That is up +16% on the projected 2031 average. That marks a +103% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CI could reach as high as $871.18, with a base case around $612.39 and support toward $462.43 — roughly +109% from $293.46. Momentum favours further upside here.
Expect CI to range from $482.94 to $929.85 through 2034. The $645.92 average target implies a +120% move from current prices. That is up +5% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CI price prediction for 2035 points to an average of $706.54 (low $523.31, high $1,028.44) — a potential gain of +141% on today's $293.46. Momentum favours further upside here.
In 2040, CI is projected to trade between $749.65 and $1,610.26, averaging $1,055.63 — a potential gain of +260% from today's $293.46. That is up +49% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The Cigna Group's 2050 outlook centres on $2,156.24, within a $1,427.74 to $3,525.67 range. That is up +104% on the projected 2040 average. That marks a +635% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CI today (≈ 3.407619 CI) could be worth
$7,347.64
+$6,347.64 (+635%) by 2050 · US Dollar
Based on the average projected CI price of $2,156.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CIwould be worth at today's price.
$1,000 invested in CI on Jul 10, 2025 (≈ 3.238552 CI) would be worth
$950.39
-$49.61 (-5.0%) today · 0.95× · US Dollar
Based on a CI entry price of $308.78 vs. today's $293.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $287.77 | $1,019.77 | +2.0% |
| 1 month ago | $295.81 | $992.06 | -0.8% |
| 3 months ago | $271.25 | $1,081.88 | +8.2% |
| 6 months ago | $276.02 | $1,063.18 | +6.3% |
| 1 year ago | $308.78 | $950.39 | -5.0% |
| All time (5.0y) ago | $235.56 | $1,245.8 | +24.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CI forecast.
Our base-case forecast reaches $590.00 around 2032.
Implied market cap at $590.00: $156.07B
The multi-year forecast shows a bullish path beyond 2026. Notably, 2030 is projected to have an average price of $416.23 with a 47.6% ROI, and a bullish signal. By 2040, the average is expected to reach $965.01 with a 242.1% ROI, continuing the bullish trend. The 2050 forecast envisions an average of $1,952.64 with a 592.2% ROI, also labeled bullish.
These figures imply a strong upward trajectory over the long term, though they are estimates and carry uncertainty. The outlook highlights substantial potential gains in a high-growth horizon, but actual results will depend on future market conditions and company performance.
Tap a question to reveal the answer.
Avg $416.23, min $324.92, max $567.86; ROI 47.6%; sentiment BULLISH.
In 2029 the max forecast is $496.20, which is below $500; by 2030 the max forecast is $567.86.
Current price is $281.08? No. Actual: $282.08. Market cap is $74.62B.
$256.80 to $309.85.
Avg $965.01, min $685.03, max $1,472.62; ROI 242.1%; sentiment BULLISH.
The Cigna Group Community Discussion
0Share your The Cigna Group price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.